Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis

BACKGROUND & AIMS: Increased serum bile acids (BAs) have been observed in patients with non-alcoholic steatohepatitis (NASH). Pegbelfermin (PGBF), a polyethylene glycol-modified (PEGylated) analogue of human fibroblast growth factor 21 (FGF21), significantly decreased hepatic steatosis and impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yi, Decato, Benjamin E., Charles, Edgar D., Shevell, Diane E., McNaney, Colleen, Shipkova, Petia, Apfel, Abraham, Tirucherai, Giridhar S., Sanyal, Arun J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689226/
https://www.ncbi.nlm.nih.gov/pubmed/34977519
http://dx.doi.org/10.1016/j.jhepr.2021.100392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689226/
https://www.ncbi.nlm.nih.gov/pubmed/34977519
http://dx.doi.org/10.1016/j.jhepr.2021.100392

Ejemplares similares